Avian polynucleotide formula
AssigneeMerial Limited
InventorsJean-Christophe Audonnet, Annabelle Bouchardon, Michel Riviere
Life of this patent
Estimating the term…
Abstract
The avian vaccine formula comprises at least three polynucleotide vaccine valencies each comprising a plasmid integrating, so as to express it in vivo in the host cells, a gene with one avian pathogen valency, these valencies being selected from the group consisting of Marek's disease virus, Newcastle disease virus, infectious bursal disease virus, infectious bronchitis virus, infectious anaemia virus, the plasmids comprising, for each valency, one or more of the genes selected from the group consisting of gB and gD for the Marek's disease virus, HN and F for the Newcastle disease virus, VP2 for the infectious bursal disease virus, S, M and N for the infectious bronchitis virus, C+NS1 for the infectious anaemia virus.
Claims12
An immunogenic composition for inducing in an avian host an immunological response against Newcastle disease comprising a plasmid that contains and expresses in vivo in an avian host cell a nucleic acid molecule having the sequence encoding Newcastle disease virus HN protein and a pharmaceutically acceptable carrier.
An immunogenic composition for inducing in an avian host an immunological response against infectious bursal disease comprising a plasmid that contains and expresses in vivo in an avian host cell a nucleic acid molecule having the sequence VP2 protein.
An immunogenic composition for inducing in an avian host an immunological response against infectious anaemia virus comprising at least one plasmid that contains and expresses in vivo in an avian host cell a nucleic acid molecule having the sequence encoding infectious anaemia virus C protein and a nucleic acid molecule having the sequence encoding infectious anaemia virus NS I protein.
Dependencies are inferred from the claim text.